The DOI matches its Crossref record; 500 of the 501 references it cites were found in a registry or an index, and 1 are not checked yet.
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
Open accessAbstract
This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another limitation is that we evaluated service use over a one-year period. This might underestimate utilization of services in the longer run, as there is some evidence that individuals with persistent symptoms of common mental disorders tend to use services if followed for a longer period than one year (Baldwin et al., 2014).”
From Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries (2018) · cites this paper as Baldwin et al., 2014
In the citing paper
“First, SSRI pharmacotherapy guidelines differ across the various anxiety and related conditions 69 .”
From The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management (2021) · cites this paper as [69]
In the citing paper
“Second, agents other than SSRIs have different efficacy across different anxiety and related disorders 69 .”
From The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management (2021) · cites this paper as [69]
In the citing paper
“Psychotherapy as one of the first-line treatments for depressive and anxiety disorders (4–6) is provided for only 10–15% of those who receive treatment (7).”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“Most adults with anxiety disorders report an onset of symptoms in childhood or adolescence (Jones, 2013; Kessler et al., 2005), and some recommendations (for example those pertaining to obsessive-compulsive disorder and social phobia) will therefore be potentially applicable to adolescent patients.”
BackgroundDiagnostic and Statistical Manual of Mental Disorders(DSM)
(2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n182 · Cited by 10,830
Posttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379 · cited 1×
“For example, the US National Comorbidity Survey found that 60.7% of men and 51.2% of women reported exposure to at least one traumatic event, but post-traumatic stress disorder had a lifetime prevalence of 7.8% [I] (Kessler et al., 1995).”
BackgroundInfluentialThe size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754 · cited 5×
“Obsessive-compulsive disorder has an estimated 12-month prevalence of 0.7–1.0% [I] (Kessler et al., 2012; Wittchen et al., 2011), and an estimated lifetime morbid risk of 2.7% [I] (Kessler et al., 2012).”
BackgroundInfluentialSelf-citationKessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947 · cited 1×
“Obsessive-compulsive disorder has an estimated 12-month prevalence of 0.7–1.0% [I] (Kessler et al., 2012; Wittchen et al., 2011), and an estimated lifetime morbid risk of 2.7% [I] (Kessler et al., 2012).”
BackgroundInfluentialMendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,858
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723 · cited 2×
“Using estimates to calculate the size of the population in the European Union that would be affected (69.1 million people), it was estimated that, in 2010, anxiety disorders (excluding post-traumatic stress disorder) cost close to €66 billion [I] (Gustavsson et al., 2011).”
BackgroundInfluentialSelf-citationDavis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719 · cited 2×
“, 1979), though fluvoxamine has been shown to enhance the efficacy of exposure therapy [I (PCT)] (Cottraux et al., 1990) and multi-modal CBT [I (PCT)] (Hohagen et al.”
Research works printed but not linked: 44
- Andersson G, 2012, Stud Health Technol Inform, 181, 3
- 10.1080/15622970802465807 · DOI · Paper page
- Bisson J, 2007, Cochrane Database Syst Rev, 3, CD003388
- Bower P, 2001, Br J Gen Pract, 51, 838
- Campbell Burton CA, 2011, Cochrane Database Syst Rev (Online), CD008860
- Canton J, 2012, Neuropsychiatr Dis Treat, 8, 203
- Cape J, 1999, Br J Gen Pract, 49, 875
- Chessick CA, 2006, Cochrane Database Syst Rev, 19, CD006115
- Cipriani A, 2012, Cochrane Database Syst Rev (Online), 10, CD006533
- Dieleman GC, 2008, Tijdschr Psychiatr, 50, 43
- Durham RC, 2005, Health Technol Assess (Rockv), 9, 1
- Ehrenreich JT, 2008, Psicol Conductual, 16, 389
- Fallon BA, 2008, J Clin Pharmacol, 28, 638
- Gelpin E, 1996, J Clin Psychiatry, 57, 390
- Gillies D, 2012, Cochrane Database Syst Rev, 12, CD006726
- Guaiana G, 2010, Cochrane Database Syst Rev, 8, CD006815
- Hosenbocus S, 2011, J Can Acad Child Adolesc Psychiatry, 20, 60
- Hovland A, 2012, Behav Cogn Psychother, 5, 1
- Hyde J, 2005, Br J Gen Pract, 55, 846
- James A, 2005, Cochrane Database Syst Rev, 4, CD004690
- Kadam UT, 2001, Br J Gen Pract, 51, 375
- Khan A, 2013, Ann Clin Psychiatry, 25, E7
- Krisanaprakornit T, 2006, Cochrane Database Systemic Reviews, 25, CD004998
- Meibach RC, 1987, J Clin Psychiatry, 48, 355
- 10.1176/ps.2006.57.12.1745 · doi:10.1176/ps.2006.57.12.1745
- National Institute for Health and Clinical Excellence., 2011, NICE clinical guideline 123
- National Institute for Clinical Excellence (NICE), 2005, Post-Traumatic Stress Disorder (PTSD): The Management of PTSD in Adults and Children in Primary and Secondary Care. NICE Guideline 26
- National Institute for Health and Care Excellence, 2013, Social Anxiety Disorder: Recognition, Assessment and Treatment. NICE Clinical Guideline 159
- Nutt DJ, 2006, J Clin Psychiatry, 67, 46
- Ontiveros A, 1992, J Psychiatry Neurosci, 17, 78
- Pollack MH, 1994, J Clin Psychiatry, 55, 200
- Roy-Byrne P, 2002, J Am Board Fam Pract, 15, 443
- Schatzberg A, 2006, J Clin Psychiatry, 67, 27
- Seedat S, 2004, J Clin Psychiatry, 65, 244
- Stein MB, 1999, J Fam Pract, 48, 514
- Thomson AB, 2007, Cochrane Database Syst Rev, CD006520
- Tiffon L, 1994, J Clin Psychiatry, 55, 66
- Tollefson GD, 1994, J Clin Psychiatry, 55, 69
- Van Rijswijk E, 2009, BMC Family Practice, 10
- Vermani M, 2011, Prim Care Companion CNS Disord, 13
- Watanabe N, 2011, Cochrane Database Syst Rev, CD006528
- Wittchen HU, 2002, J Clin Psychiatry, 63, 24
- Wood DP, 2009, Stud Health Technol Inform, 144, 223
- World Health Organisation, 1992, ICD-10 Classification of Mental and Behavioural Disorders
Cited by
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079
Self-citationGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
“, 2014), anxiety disorders (Baldwin et al., 2014) or substance misuse (Lingford-Hughes et al.”
Dhir, A., Yossatorn, Y., Kaur, P., & Chen, S. (2018) · International Journal of Information Management · doi:10.1016/j.ijinfomgt.2018.01.012 · Cited by 1,033
“…antecedents and outcomes of anxiety, such as psychiatric and physiological illnesses, substance abuse, emotional malfunctions, exhaustion, distress and even suicidal commitment (Baldwin et al., 2014; Fernández et al., 2016; Foster & Neufeld, 2013; Katzman et al., 2011; Kuss & Gri ffi ths, 2011).”
BackgroundTreatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Self-citationAlonso, J., Liu, Z., Evans-Lacko, S., Sadikova, E., Sampson, N., Chatterji, S., Abdulmalik, J., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22711 · Cited by 716
“This might underestimate utilization of services in the longer run, as there is some evidence that individuals with persistent symptoms of common mental disorders tend to use services if followed for a longer period than one year (Baldwin et al., 2014).”
Influential
Metadata
- Authors
- Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., Malizia, A., McCrone, P., Nabarro, D., O’Neill, C., Scott, J., van der Wee, N., & Wittchen, H.-U.
- Affiliations
- University of Cape Town (ZA)
- University of Manchester (GB)
- Imperial College London (GB)
- Karolinska Institutet (SE)
- University of Göttingen (DE)
- Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen (UMCG), Groningen, The Netherlands
- Cambridgeshire and Peterborough NHS Foundation Trust (GB)
- Centre for Addiction and Mental Health (CA)
- University of Hertfordshire (GB)
- Anxiety UK, Manchester, UK
- North Bristol NHS Trust (GB)
- King's College London (GB)
- OCD Action, London, UK
- Newcastle University (GB)
- Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
- Institute of Clinical Psychology and Psychotherapy, Technical University Dresden, Dresden, Germany
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-04-08
- Volume
- 28
- Issue
- 5
- Pages
- 403-439
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2140107414
- Cited by
- 676
- References
- 500
- Citations by year
- 2026: 25 · 2025: 49 · 2024: 75 · 2023: 60 · 2022: 46 · 2021: 63 · 2020: 59 · 2019: 59 · 2018: 57 · 2017: 51 · 2016: 72 · 2015: 45 · 2014: 14
- FWCI
- 84.27
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- other-oa
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- GRO (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Eli Lilly and Company
- Pfizer
- University of Southampton
- Servier
- H. Lundbeck A/S
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- anxiety disorders, post-traumatic stress disorder, obsessive-compulsive disorder, pharmacotherapy, evidence-based recommendations, treatment-resistant anxiety, combination therapy, long-term treatment, acute treatment, clinical management
- MeSH terms
- Antidepressive Agents, Anxiety Disorders, Decision Making, Delivery of Health Care, Humans, Obsessive-Compulsive Disorder, Psychopharmacology, Stress Disorders, Post-Traumatic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. https://app.cochat.ai/papers/10.1177/0269881114525674
- The paper
- Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., Malizia, A., McCrone, P., Nabarro, D., O’Neill, C., Scott, J., van der Wee, N., & Wittchen, H.-U. (2014). Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881114525674
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.